Literature DB >> 25756433

Statin intolerance: reconciling clinical trials and clinical experience.

Connie B Newman1, Jonathan A Tobert2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25756433     DOI： 10.1001/jama.2015.1335

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

Review 1.  [Diagnostics and treatment of statin-associated muscle symptoms].

Authors:  Ursula Kassner; Stefanie Grunwald; Dominik Spira; Nikolaus Buchmann; Thomas Bobbert; Elisabetta Gazzerro; Tim Hollstein; Simone Spuler; Elisabeth Steinhagen-Thiessen
Journal:  Internist (Berl)       Date:  2021-06-18       Impact factor: 0.743

2.  PCSK9 Inhibitors: A Technology Worth Paying For?

Authors:  William S Weintraub; Samuel S Gidding
Journal:  Pharmacoeconomics       Date:  2016-03       Impact factor: 4.981

Review 3.  Treatment Options for Statin-Associated Muscle Symptoms.

Authors:  Ulrich Laufs; Hubert Scharnagl; Martin Halle; Eberhard Windler; Matthias Endres; Winfried März
Journal:  Dtsch Arztebl Int       Date:  2015-10-30       Impact factor: 5.594

Review 4.  PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab.

Authors:  Dirk J Blom; Ricardo Dent; Rita C Castro; Peter P Toth
Journal:  Vasc Health Risk Manag       Date:  2016-05-09

Review 5.  Lipids, blood pressure and kidney update 2015.

Authors:  Maciej Banach; Wilbert S Aronow; Maria-Corina Serban; Jacek Rysz; Luminita Voroneanu; Adrian Covic
Journal:  Lipids Health Dis       Date:  2015-12-30       Impact factor: 3.876

Review 6.  Statin tolerability: In defence of placebo-controlled trials.

Authors:  Jonathan A Tobert; Connie B Newman
Journal:  Eur J Prev Cardiol       Date:  2015-08-28       Impact factor: 7.804

7.  ANMCO Position Paper: diagnostic-therapeutic pathway in patients with hypercholesterolaemia and statin intolerance.

Authors:  Michele Massimo Gulizia; Furio Colivicchi; Marcello Arca; Maurizio Giuseppe Abrignani; Gian Piero Perna; Gian Francesco Mureddu; Federico Nardi; Carmine Riccio
Journal:  Eur Heart J Suppl       Date:  2017-05-02       Impact factor: 1.803

Review 8.  Management of Dyslipidemia in Type 2 Diabetes: Recent Advances in Nonstatin Treatment.

Authors:  Kazutoshi Sugiyama; Yoshifumi Saisho
Journal:  Diseases       Date:  2018-05-24

Review 9.  Statin Intolerance: the Clinician's Perspective.

Authors:  Tomáš Stulc; Richard Ceška; Antonio M Gotto
Journal:  Curr Atheroscler Rep       Date:  2015-12       Impact factor: 5.113

10.  Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study.

Authors:  Erik Stroes; John R Guyton; Norman Lepor; Fernando Civeira; Daniel Gaudet; Gerald F Watts; Marie T Baccara-Dinet; Guillaume Lecorps; Garen Manvelian; Michel Farnier
Journal:  J Am Heart Assoc       Date:  2016-09-13       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.